Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata)

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1489-1497

  Siebenhaar, Frank ^a,b   Sharov, Andrey A ^a   Peters, Eva M J ^b   Sharova, Tatyana Y ^a   Syska, Wolfgang ^a,b   Mardaryev, Andrei N ^a   Freyschmidt Paul, Pia ^c   Sundberg, John P ^d   Maurer, Marcus ^b   Botchkarev, Vladimir A ^a,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d JACKSON LABORATORY   (United States)

^e UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; MEMBRANE METALLOENDOPEPTIDASE; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; SUBSTANCE P;

ALOPECIA AREATA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HAIR FOLLICLE; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MAST CELL DEGRANULATION; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GRANZYMES; HAIR FOLLICLE; IMMUNOLOGIC FACTORS; MAST CELLS; MICE; MICE, INBRED C3H; NEPRILYSIN; NERVE FIBERS; RECEPTORS, NEUROKININ-1; SIGNAL TRANSDUCTION; SUBSTANCE P;

EID: 34248508667     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700704     Document Type: Article

References (67)

1. Ansel JC, Brown JR, Payan DG, Brown MA (1993) Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150:4478-85
2. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R (2001) Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 15:2536-8
3. Arck PC, Handjiski B, Kuhlmei A, Peters EM, Knackstedt M, Peter A et al. (2005) Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med 83:386-96
4. Arck PC, Handjiski B, Peters EM, Peter AS, Hagen E, Fischer A et al. (2003) Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 162:803-14
5. Barry M, Bleackley RC (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2:401-9
6. Botchkarev VA, Botchkareva NV, Albers KM, Chen L-H, Welker P, Paus R (2000) A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J 14:1931-42
7. Botchkarev VA, Botchkareva NV, Nakamura M, Huber O, Funa K, Lauster R et al. (2001) Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J 15:2205-14
8. Botchkarev VA, Botchkareva NV, Roth W, Nakamura M, Chen L-H, Herzog W et al. (1999a) Noggin is a mesenchymally-derived stimulator of hair follicle induction. Nature Cell Biol 1:158-64
9. Botchkarev VA, Botchkareva NV, Welker P, Metz M, Subramaniam A, Lewin GR et al. (1999b) A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control. FASEB J 13:395-410
10. Botchkarev VA, Eichmuller S, Johansson O, Paus R (1997a) Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol 386:379-95
11. Botchkarev VA, Eichmuller S, Peters EM, Pietsch P, Johansson O, Maurer M et al. (1997b) A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell-nerve fiber contacts in murine skin. Arch Dermatol Res 289:292-302
12. Botchkarev VA, Welker P, Albers KM, Botchkareva NV, Metz M, Lewin GR et al. (1998) A new role for neurotrophin-3: involvement in the control of hair follicle regresssion (catagen). Am J Pathol 153:785-99
13. Colpaert FC, Donnerer J, Lembeck F (1983) Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci 32:1827-34
14. Foreman JC (1987) Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol 82:366-71
15. Freyschmidt-Paul P, Hamm H, Happle R, Hoffmann R (1999a) Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone. Eur J Dermatol 9:111-4
16. Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D et al. (1999b) Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 113:61-8
17. Frieri M (2003) Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol 90:34-40
18. Gilhar A, Kalish RS (2006) Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 1:64-9
19. Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS (1999) Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Investig Dermatol Symp Proc 4:207-10
20. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62-7
21. Grady E, Bohm S, McConalogue K, Garland A, Ansel J, Olerud J et al. (1997) Mechanisms attenuating cellular responses to neuropeptides: extracellular degradation of ligands and desensitization of receptors. J Investig Dermatol Symp Proc 2:69-75
22. Gupta MA, Gupta AK, Watteel GN (1997) Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 77:296-8
23. Hoffman U, Tokura Y, Nishijima T, Takigawa M, Paus R (1996) Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. J Invest Dermatol 106:598-604
24. Hoffmann R (1999) The potential role of cytokines and T cells in alopecia areata. J Investig Dermatol Symp Proc 4:235-8
25. Hordinsky M, Ericson M (2004) Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc 9:73-8
26. Hordinsky MK, Ericson ME (1996) Relationship between follicular nerve supply and alopecia. Dermatol Clinics 14:651-60
27. Hordinsky MK, Kennedy W, Wendelschafer-Crabb G, Lewis S (1995) Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 104(Suppl):28S-9S
28. Kang BN, Kim HJ, Jeong KS, Park SJ, Kim SH, Kim SR et al. (2004) Regulation of leukocyte function-associated antigen 1-mediated adhesion by somatostatin and substance P in mouse spleen cells. Neuroimmunomodulation 11:84-92
29. Katayama I, Bae SJ, Hamasaki Y, Igawa K, Miyazaki Y, Yokozeki H et al. (2001) Stress response, tachykinin, and cutaneous inflammation. J Investig Dermatol Symp Proc 6:81-6
30. Kleij HP, Ma D, Redegeld FA, Kraneveld AD, Nijkamp FP, Bienenstock J (2003) Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 171:2074-9
31. Lang K, Drell TL, Niggemann B, Zanker KS, Entschladen F (2003) Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett 90:165-72
32. Legat FJ, Armstrong CA, Ansel JC (2002) The cutaneous neurosensory system in skin disease. Arch Dermatol 18:91-109
33. Lindsey KQ, Caughman SW, Olerud JE, Bunnett NW, Armstrong CA, Ansel JC (2000) Neural regulation of endothelial cell-mediated inflammation. J Investig Dermatol Symp Proc 5:74-8
34. Maurer M, Fischer E, Handjiski B, von_Stebut E, Algermissen B, Bavandi A et al. (1997) Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 77:319-32
35. McDonagh AJ, Messenger AG (2001) Alopecia areata. Clin Dermatol 19:141-7
36. McElwee KJ, Boggess D, King LE Jr, Sundberg JP (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111:797-803
37. McElwee KJ, Freyschmidt-Paul P, Sundberg JP, Hoffmann R (2003) The pathogenesis of alopecia areata in rodent models. J Investig Dermatol Symp Proc 8:6-11
38. McElwee KJ, Hoffmann R (2002) Alopecia areata - animal models. Clin Exp Dermatol 27:410-7
39. Misery L, Rousset H (2001) Is alopecia areata a psychosomatic disease? Rev Med Interne 22:274-9
40. Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA et al. (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 117:3-15
41. Nibbering PH, Leijh PC, van Furth R (1987) Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology 62:171-6
42. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F (2004) The role of substance P in inflammatory disease. J Cell Physiol 201:167-80
43. Olerud JE, Usui ML, Seckin D, Chiu DS, Haycox CL, Song IS et al. (1999) Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol 112:873-81
44. Ostlere LS, Cowen T, Rustin MH (1995) Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 20:462-7
45. Paus R, Heinzelmann T, Schultz KD, Furkert J, Fechner K, Czarnetzki BM (1994) Hair growth induction by substance P. Lab Invest 71:134-40
46. Paus R, Ito N, Takigawa M, Ito T (2003) The hair follicle and immune privilege. J Investig Dermatol Symp Proc 8:188-94
47. Paus R, Nickoloff BJ, Ito T (2005) A 'hairy' privilege. Trends Immunol 26:32-40
48. Paus R, Theoharides TC, Arck PC (2006) Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 27:32-9
49. Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R (2001) Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol 116:236-45
50. Peters EM, Kuhlmei A, Tobin DJ, Muller-Rover S, Klapp BF, Arck PC (2005) Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 19:252-62
51. Rossi R, Del Bianco E, Isolani D, Baccari MC, Cappugi P (1997) Possible involvement of neuropeptidergic sensory nerves in alopecia areata. Neuroreport 8:1135-8
52. Saban R, Gerard NP, Saban MR, Nguyen NB, DeBoer DJ, Wershil BK (2002) Mast cells mediate substance P-induced bladder inflammation through an NK (1) receptor-independent mechanism. Am J Physiol Renal Physiol 283:F616-29
53. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81-96
54. Scholzen TE, Luger TA (2004) Neutral endopeptidase and angiotensin-converting enzyme - key enzymes terminating the action of neuroendocrine mediators. Exp Dermatol 13(Suppl 4):22-6
55. Scholzen TE, Steinhoff M, Bonaccorsi P, Klein R, Amadesi S, Geppetti P et al. (2001) Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol 166:1285-91
56. Shapiro J, Madani S (1999) Alopecia areata: diagnosis and management. Int J Dermatol 38(Suppl 1):19-24
57. Sharov A, Fessing M, Atoyan R, Sharova TY, Haskell-Luevano C, Weiner L et al. (2005) Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci USA 102:93-8
58. Sharov AA, Li GZ, Palkina TN, Sharova TY, Gilchrest BA, Botchkarev VA (2003a) Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol 120:27-35
59. Sharov AA, Siebenhaar F, Sharova TY, Botchkareva NV, Gilchrest BA, Botchkarev VA (2004) Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res 64:6266-70
60. Sharov AA, Weiner L, Sharova TY, Siebenhaar F, Atoyan R, Reginato AM et al. (2003b) Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J 22:2992-3003
61. Steinman L (2004) Elaborate interactions between the immune and nervous systems. Nat Immunol 5:575-81
62. Sundberg JP, Boggess D, Montagutelli X, Hogan ME, King LE Jr (1995a) C3H/HeJ mouse model for alopecia areata. J Invest Dermatol 104:0022-202x
63. Sundberg JP, Cordy WR, King LEJ (1995b) Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-56
64. Sundberg JP, King Jr LE (2003) Mouse alopecia areata models: an array of data on mechanisms and genetics. J Investig Dermatol Symp Proc 8:173-5
65. Tanaka T, Danno K, Ikai K, Imamura S (1988) Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 90:399-401
66. Toyoda M, Makino T, Kagoura M, Morohashi M (2001) Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 144:46-54
67. Waterhouse NJ, Clarke CJ, Sedelies KA, Teng MW, Trapani JA (2004) Cytotoxic lymphocytes; instigators of dramatic target cell death. Biochem Pharmacol 68:1033-40